2,520,000 options issued to key Tissue Therapies’ staff and contractors under the current Equity Option Plan approved at AGM held on 12 November 2012. Not sure how that comes to 10 or 15%. The 15& has to do with the price not the number of options
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential